FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376108285> ?p ?o ?g. }

• W4376108285 endingPage "1239" @default.
• W4376108285 startingPage "1223" @default.
• W4376108285 abstract "With distinct mechanisms of action, the combination of tropifexor (TXR) and cenicriviroc (CVC) may provide an effective treatment for NASH. This randomized, multicenter, double-blind, phase 2b study assessed the safety and efficacy of TXR and CVC combination, compared with respective monotherapies.Patients (N = 193) were randomized 1:1:1:1 to once-daily TXR 140 μg (TXR 140 ), CVC 150 mg (CVC), TXR 140 μg + CVC 150 mg (TXR 140 + CVC), or TXR 90 μg + CVC 150 mg (TXR 90 + CVC) for 48 weeks. The primary and secondary end points were safety and histological improvement, respectively. Rates of adverse events (AEs) were similar across treatment groups. Pruritus was the most frequently experienced AE, with highest incidence in the TXR 140 group (40.0%). In TXR and combination groups, alanine aminotransferase (ALT) decreased from baseline to 48 weeks (geometric mean change: -21%, TXR 140 ; -16%, TXR 140 + CVC; -13%, TXR 90 + CVC; and +17%, CVC). Reductions in body weight observed at week 24 (mean changes from baseline: TXR 140 , -2.5 kg; TXR 140 + CVC, -1.7 kg; TXR 90 + CVC, -1.0 kg; and CVC, -0.1 kg) were sustained to week 48. At least 1-point improvement in fibrosis stage/steatohepatitis resolution without worsening of fibrosis was observed in 32.3%/25.8%, 31.6%/15.8%, 29.7%/13.5%, and 32.5%/22.5% of patients in the TXR 140 , CVC, TXR 140 + CVC, and TXR 90 + CVC groups, respectively.The safety profile of TXR + CVC combination was similar to respective monotherapies, with no new signals. TXR monotherapy showed sustained ALT and body weight decreases. No substantial incremental efficacy was observed with TXR + CVC combination on ALT, body weight, or in histological end points compared with monotherapy." @default.
• W4376108285 created "2023-05-12" @default.
• W4376108285 creator A5011069724 @default.
• W4376108285 creator A5016102803 @default.
• W4376108285 creator A5019990218 @default.
• W4376108285 creator A5020679784 @default.
• W4376108285 creator A5020947516 @default.
• W4376108285 creator A5026415059 @default.
• W4376108285 creator A5026973335 @default.
• W4376108285 creator A5027119775 @default.
• W4376108285 creator A5030205518 @default.
• W4376108285 creator A5037852458 @default.
• W4376108285 creator A5037989560 @default.
• W4376108285 creator A5038545834 @default.
• W4376108285 creator A5040631294 @default.
• W4376108285 creator A5040941854 @default.
• W4376108285 creator A5043846829 @default.
• W4376108285 creator A5052059601 @default.
• W4376108285 creator A5059068278 @default.
• W4376108285 creator A5060169505 @default.
• W4376108285 creator A5064974711 @default.
• W4376108285 creator A5070639714 @default.
• W4376108285 creator A5070970519 @default.
• W4376108285 creator A5071529890 @default.
• W4376108285 creator A5072395263 @default.
• W4376108285 creator A5073702849 @default.
• W4376108285 creator A5076455574 @default.
• W4376108285 creator A5085538125 @default.
• W4376108285 date "2023-05-11" @default.
• W4376108285 modified "2023-10-05" @default.
• W4376108285 title "Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study" @default.
• W4376108285 cites W1882608036 @default.
• W4376108285 cites W1993702135 @default.
• W4376108285 cites W2020730100 @default.
• W4376108285 cites W2067740038 @default.
• W4376108285 cites W2106768039 @default.
• W4376108285 cites W2204688218 @default.
• W4376108285 cites W2388847993 @default.
• W4376108285 cites W2467384826 @default.
• W4376108285 cites W2746863374 @default.
• W4376108285 cites W2769380893 @default.
• W4376108285 cites W2770129291 @default.
• W4376108285 cites W2810423511 @default.
• W4376108285 cites W2946054531 @default.
• W4376108285 cites W2979775329 @default.
• W4376108285 cites W2989506192 @default.
• W4376108285 cites W2993083975 @default.
• W4376108285 cites W2994629683 @default.
• W4376108285 cites W3001786135 @default.
• W4376108285 cites W3010370531 @default.
• W4376108285 cites W3048658023 @default.
• W4376108285 cites W3082261340 @default.
• W4376108285 cites W3101728747 @default.
• W4376108285 cites W3127206578 @default.
• W4376108285 cites W3133101076 @default.
• W4376108285 cites W3194233908 @default.
• W4376108285 cites W3204219369 @default.
• W4376108285 cites W4206982035 @default.
• W4376108285 cites W4280622190 @default.
• W4376108285 cites W4283791928 @default.
• W4376108285 cites W4321077653 @default.
• W4376108285 cites W4365458272 @default.
• W4376108285 doi "https://doi.org/10.1097/hep.0000000000000439" @default.
• W4376108285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37162151" @default.
• W4376108285 hasPublicationYear "2023" @default.
• W4376108285 type Work @default.
• W4376108285 citedByCount "4" @default.
• W4376108285 countsByYear W43761082852023 @default.
• W4376108285 crossrefType "journal-article" @default.
• W4376108285 hasAuthorship W4376108285A5011069724 @default.
• W4376108285 hasAuthorship W4376108285A5016102803 @default.
• W4376108285 hasAuthorship W4376108285A5019990218 @default.
• W4376108285 hasAuthorship W4376108285A5020679784 @default.
• W4376108285 hasAuthorship W4376108285A5020947516 @default.
• W4376108285 hasAuthorship W4376108285A5026415059 @default.
• W4376108285 hasAuthorship W4376108285A5026973335 @default.
• W4376108285 hasAuthorship W4376108285A5027119775 @default.
• W4376108285 hasAuthorship W4376108285A5030205518 @default.
• W4376108285 hasAuthorship W4376108285A5037852458 @default.
• W4376108285 hasAuthorship W4376108285A5037989560 @default.
• W4376108285 hasAuthorship W4376108285A5038545834 @default.
• W4376108285 hasAuthorship W4376108285A5040631294 @default.
• W4376108285 hasAuthorship W4376108285A5040941854 @default.
• W4376108285 hasAuthorship W4376108285A5043846829 @default.
• W4376108285 hasAuthorship W4376108285A5052059601 @default.
• W4376108285 hasAuthorship W4376108285A5059068278 @default.
• W4376108285 hasAuthorship W4376108285A5060169505 @default.
• W4376108285 hasAuthorship W4376108285A5064974711 @default.
• W4376108285 hasAuthorship W4376108285A5070639714 @default.
• W4376108285 hasAuthorship W4376108285A5070970519 @default.
• W4376108285 hasAuthorship W4376108285A5071529890 @default.
• W4376108285 hasAuthorship W4376108285A5072395263 @default.
• W4376108285 hasAuthorship W4376108285A5073702849 @default.
• W4376108285 hasAuthorship W4376108285A5076455574 @default.
• W4376108285 hasAuthorship W4376108285A5085538125 @default.
• W4376108285 hasBestOaLocation W43761082851 @default.
• W4376108285 hasConcept C126322002 @default.
• W4376108285 hasConcept C71924100 @default.

• next